ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 222 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,555,570 | -16.5% | 183,887 | +8.1% | 0.01% | -13.3% |
| Q2 2023 | $7,848,417 | +7.4% | 170,137 | -6.6% | 0.02% | +7.1% |
| Q1 2023 | $7,307,701 | +43.9% | 182,237 | +66.2% | 0.01% | +40.0% |
| Q4 2022 | $5,079,712 | +31.5% | 109,642 | +17.4% | 0.01% | +25.0% |
| Q3 2022 | $3,864,000 | +1496.7% | 93,375 | +2691.5% | 0.01% | – |
| Q1 2022 | $242,000 | +7.6% | 3,345 | +33.7% | 0.00% | – |
| Q3 2021 | $225,000 | -87.3% | 2,502 | -86.6% | 0.00% | -100.0% |
| Q2 2021 | $1,773,000 | -51.4% | 18,608 | -41.9% | 0.00% | -50.0% |
| Q1 2021 | $3,649,000 | -33.3% | 32,054 | -18.9% | 0.01% | -45.5% |
| Q4 2020 | $5,471,000 | +63.6% | 39,520 | -2.9% | 0.01% | +57.1% |
| Q3 2020 | $3,344,000 | +26.3% | 40,685 | +20.0% | 0.01% | +16.7% |
| Q2 2020 | $2,648,000 | +23.0% | 33,894 | -30.1% | 0.01% | 0.0% |
| Q1 2020 | $2,153,000 | -18.7% | 48,487 | -21.8% | 0.01% | +20.0% |
| Q4 2019 | $2,648,000 | +54.7% | 62,030 | +55.1% | 0.01% | +66.7% |
| Q3 2019 | $1,712,000 | -32.0% | 40,005 | +0.8% | 0.00% | -40.0% |
| Q2 2019 | $2,518,000 | +10.7% | 39,673 | +20.9% | 0.01% | +25.0% |
| Q1 2019 | $2,275,000 | +91.7% | 32,802 | +20.0% | 0.00% | +33.3% |
| Q4 2018 | $1,187,000 | -78.7% | 27,327 | -62.5% | 0.00% | -72.7% |
| Q3 2018 | $5,565,000 | +161.3% | 72,813 | +162.7% | 0.01% | +175.0% |
| Q2 2018 | $2,130,000 | +47.6% | 27,716 | -2.0% | 0.00% | +100.0% |
| Q1 2018 | $1,443,000 | +22.3% | 28,292 | +12.6% | 0.00% | 0.0% |
| Q4 2017 | $1,180,000 | -44.8% | 25,122 | -37.4% | 0.00% | -50.0% |
| Q3 2017 | $2,137,000 | +10.3% | 40,120 | +28.7% | 0.00% | +33.3% |
| Q2 2017 | $1,937,000 | +2.1% | 31,184 | +11.4% | 0.00% | 0.0% |
| Q1 2017 | $1,897,000 | +104.6% | 27,989 | +111.9% | 0.00% | +50.0% |
| Q4 2016 | $927,000 | – | 13,209 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |